The role of MRI in assessing cognitive impairment changes
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20233552Keywords:
Dementia, AD, MRI, Cerebral atrophy, Microbleeds, White matter hyperintensities, Lacunes, Strategic infarctsAbstract
Aging brings about various changes in the brain, leading to cognitive alterations that are increasingly relevant with extended life expectancy. Dementia, characterized by chronic cognitive impairment, is on the rise due to longer life expectancy, imposing a substantial burden on healthcare systems. Dementia encompasses conditions like Alzheimer's disease (AD), vascular dementia (VaD), Lewy body dementia (LBD), and frontotemporal dementia, each with its distinct symptoms and progression. Magnetic resonance imaging (MRI), especially 3T MRI, plays a crucial role in monitoring and diagnosing dementia, aiding in patient selection for emerging therapies. Study involves a comprehensive literature search without restrictions on date, language, age/publication type. Dementia can be divided into neurodegenerative and nondegenerative categories, with AD being the most prevalent. Diagnosis relies on clinical evaluation, supported by neuroimaging techniques like MRI. Various MRI findings, such as cerebral atrophy, microbleeds, white matter hyperintensities, lacunes, and strategic infarcts, offer insights into dementia-related brain changes. These findings facilitate early diagnosis, prognosis, and treatment monitoring, with standardized assessment tools and volumetric analysis enhancing diagnostic accuracy. As life expectancy continues to rise, MRI's role in assessing cognitive impairment changes becomes increasingly vital in addressing the growing challenge of dementia.
References
Peters R. Ageing and the brain: This article is part of a series on ageing edited by Professor Chris Bulpitt. Postgraduate Med J. 2006;82(964):84-8.
Dartora CM, Borelli WV, Koole M, Marques da Silva AM. Cognitive Decline Assessment: A Review From Medical Imaging Perspective. Frontiers Aging Neurosci. 2021;13:704661.
Oschwald J, Guye S, Liem F. Brain structure and cognitive ability in healthy aging: a review on longitudinal correlated change. Rev Neurosci. 2019;31(1):1-57.
Álvarez-Linera Prado J, Jiménez-Huete A. Neuroimaging in dementia. Clinical–radiological correlation. Radiología (English Edition). 2019;61(1):66-81.
Jongsiriyanyong S, Limpawattana P. Mild Cognitive Impairment in Clinical Practice: A Review Article. Am J Alzheimer's Dis Other Dementias®. 2018;33(8):500-7.
Petersen RC, Lopez O, Armstrong MJ, Thomas SDG, Mary G, David G et al. Practice guideline update summary: Mild cognitive impairment. Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;90(3):126-35.
NA. 2021 Alzheimer's disease facts and figures. Alzheimer's Dementia. 2021;17(3):327-406.
Jack Jr. CR, Albert MS, Knopman DS, Guy MMcK, Reisa AS, Maria CC et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Demen. 2011;7(3):257-62.
Barakos J, Purcell D, Suhy J, Chalkias S, Burkett P, Marsica CG et al. Detection and Management of Amyloid-Related Imaging Abnormalities in Patients with Alzheimer’s Disease Treated with Anti-Amyloid Beta Therapy. J Prevention Alzheimer's Dis. 2022;9(2):211-20.
Živanović M, Aracki Trenkić A, Milošević V. The role of magnetic resonance imaging in the diagnosis and prognosis of dementia. Biomol Biomed. 2023;23(2):209-24.
Ismail Z, Black SE, Camicioli R. Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia. Alzheimer Demen. 2020;16(8):1182-95.
Schmitt T, Rieger JW. Recommendations of Choice of Head Coil and Prescan Normalize Filter Depend on Region of Interest and Task. Frontiers Neurosci. 2021;15.
Harper L, Bouwman F, Burton EJ. Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis. J Neurol Neurosur Psychiatr. 2017;88(11):908-16.
Van Someren EJW, Oosterman JM, Van Harten B. Medial temporal lobe atrophy relates more strongly to sleep-wake rhythm fragmentation than to age or any other known risk. Neurobiol Learning Memory. 2019;160:132-8.
Huang L, Chen K, Hu X, Guo Q. Differential Atrophy in the Hippocampal Subfield Volumes in Four Types of Mild Dementia. Frontiers in Neurosc. 2020;14.
Mak E, Su L, Williams GB, O’Brien JT. Neuroimaging characteristics of dementia with Lewy bodies. Alzheimer's Res Therapy. 2014;6(2):18.
Holden SK, Bettcher BM, Pelak VS. Update on posterior cortical atrophy. Curr Opinion Neurol. 2020;33(1):68-73.
Lehmann M, Koedam ELGE, Barnes J, Jonathan WB, Natalie SR, Yolande ALP et al. Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease. Neurobiol Aging. 2012;33(3):627-7.
Oldan JD, Jewells VL, Pieper B, Wong TZ. Complete Evaluation of Dementia: PET and MRI Correlation and Diagnosis for the Neuroradiologist. Am J Neuroradiol. 2021;42(6):998-1007.
Watson R, Colloby SJ, Blamire AM, Wesnes KA, Wood J, O'Brien JT. Does attentional dysfunction and thalamic atrophy predict decline in dementia with Lewy bodies? Parkinsonism Rel Disord. 2017;45:69-74.
Low A, Mak E, Malpetti M. Asymmetrical atrophy of thalamic subnuclei in Alzheimer's disease and amyloid-positive mild cognitive impairment is associated with key clinical features. Alzheimer's Dementia: Diagnosis, Assessment Dis Monitoring. 2019;11(1):690-9.
Biel D, Steiger TK, Bunzeck N. Age-related iron accumulation and demyelination in the basal ganglia are closely related to verbal memory and executive functioning. Scient Rep. 2021;11(1):9438.
Stojanov D, Vojinovic S, Aracki-Trenkic A, Aleksandar T, Daniela B-S, Srdjan L et al. Imaging Characteristics of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leucoencephalopathy (CADASIL). Biomole Biomed. 2015;15(1):1-8.
Chesebro AG, Amarante E, Lao PJ, Meier IB, Mayeux R, Brickman AM. Automated detection of cerebral microbleeds on T2*-weighted MRI. Scientific Rep. 2021;11(1):4004.
Ghaznawi R, Geerlings MI, Jaarsma-Coes MG. The association between lacunes and white matter hyperintensity features on MRI: The SMART-MR study. J Cerebral Blood Flow Metabol. 2019;39(12):2486-96.
Kalaria RN, Akinyemi R, Ihara M. Stroke injury, cognitive impairment and vascular dementia. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2016;1862(5):915-25.
Zhao L, Biesbroek JM, Shi L Wenyan L, Hugo JK, Winnie WC et al. Strategic infarct location for post-stroke cognitive impairment: A multivariate lesion-symptom mapping study. J Cerebral Blood Flow Metabol. 2018;38(8):1299-311.
